SPDL1 and non-small cell lung carcinoma: ELISA was adopted to detect the changes in the serum sPD-L1 level of patients, and it was found that the sPD-L1 expression level of NSCLC patients was higher than that of normal people, which showed a downward trend after radiotherapy.